ANDA Approvals Break Record, May Set New Normal
Executive Summary
FDA's June approval total is highest of GDUFA era, but does it signal a new elevated productivity level for the generics program?
You may also be interested in...
Is Bloom Gone From Rosy ANDA Approvals Figures?
US FDA sets a new monthly record for full approvals, but industry group argues that approvals alone aren't creating more generic competition in the market.
Is Bloom Gone From Rosy ANDA Approvals Figures?
US FDA sets a new monthly record for full approvals, but industry group argues that approvals alone aren't creating more generic competition in the market.
Gottlieb's 2018 Generic Drug Approval Goal May Be In Doubt
Thanks in large part to new elemental impurities requirements, ANDA approvals are behind the pace needed to beat 2017’s record.